Concepts (89)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Abortion, Induced | 8 | 2023 | 85 | 5.120 |
Why?
|
| Physicians | 2 | 2024 | 163 | 1.450 |
Why?
|
| Telemedicine | 2 | 2021 | 182 | 1.190 |
Why?
|
| Pregnancy | 9 | 2023 | 1549 | 1.150 |
Why?
|
| Abortion, Spontaneous | 2 | 2023 | 24 | 1.050 |
Why?
|
| Mifepristone | 2 | 2021 | 34 | 0.970 |
Why?
|
| Gynecology | 1 | 2023 | 31 | 0.880 |
Why?
|
| Obstetrics | 1 | 2023 | 37 | 0.860 |
Why?
|
| Fetal Research | 1 | 2022 | 4 | 0.840 |
Why?
|
| Hawaii | 6 | 2024 | 1929 | 0.840 |
Why?
|
| Contraception | 2 | 2023 | 57 | 0.820 |
Why?
|
| Students, Medical | 1 | 2024 | 130 | 0.810 |
Why?
|
| Rural Population | 1 | 2024 | 294 | 0.800 |
Why?
|
| Abortifacient Agents | 1 | 2021 | 11 | 0.770 |
Why?
|
| Misoprostol | 1 | 2021 | 26 | 0.770 |
Why?
|
| Menstruation | 1 | 2019 | 10 | 0.690 |
Why?
|
| Social Behavior | 1 | 2020 | 131 | 0.680 |
Why?
|
| Medical History Taking | 1 | 2019 | 33 | 0.680 |
Why?
|
| Sex Counseling | 1 | 2019 | 2 | 0.680 |
Why?
|
| Contraception, Postcoital | 1 | 2019 | 8 | 0.680 |
Why?
|
| Female | 15 | 2024 | 20969 | 0.670 |
Why?
|
| Levonorgestrel | 1 | 2019 | 16 | 0.670 |
Why?
|
| Anesthesiology | 1 | 2018 | 7 | 0.660 |
Why?
|
| Women | 1 | 2019 | 27 | 0.660 |
Why?
|
| Sexual Behavior | 2 | 2019 | 609 | 0.570 |
Why?
|
| Attitude of Health Personnel | 1 | 2018 | 198 | 0.570 |
Why?
|
| Overweight | 1 | 2019 | 247 | 0.550 |
Why?
|
| Humans | 17 | 2024 | 37093 | 0.540 |
Why?
|
| United States | 5 | 2023 | 4223 | 0.450 |
Why?
|
| Depression | 1 | 2018 | 712 | 0.410 |
Why?
|
| Retrospective Studies | 3 | 2023 | 2026 | 0.380 |
Why?
|
| Qualitative Research | 2 | 2023 | 446 | 0.360 |
Why?
|
| Adult | 5 | 2023 | 11712 | 0.320 |
Why?
|
| HIV Infections | 1 | 2019 | 2303 | 0.250 |
Why?
|
| Forecasting | 1 | 2024 | 128 | 0.220 |
Why?
|
| Women's Health | 1 | 2024 | 145 | 0.220 |
Why?
|
| Neuroblastoma | 2 | 2013 | 129 | 0.210 |
Why?
|
| Fetal Tissue Transplantation | 1 | 2022 | 4 | 0.210 |
Why?
|
| Aborted Fetus | 1 | 2022 | 5 | 0.210 |
Why?
|
| Intention | 1 | 2023 | 94 | 0.210 |
Why?
|
| Religion | 1 | 2023 | 87 | 0.210 |
Why?
|
| Linear Models | 1 | 2023 | 275 | 0.210 |
Why?
|
| Schools | 1 | 2024 | 260 | 0.200 |
Why?
|
| Abortion, Legal | 1 | 2021 | 6 | 0.200 |
Why?
|
| Aftercare | 1 | 2021 | 19 | 0.190 |
Why?
|
| Ultrasonography, Prenatal | 1 | 2021 | 33 | 0.190 |
Why?
|
| Guam | 1 | 2021 | 79 | 0.190 |
Why?
|
| Young Adult | 2 | 2023 | 4268 | 0.190 |
Why?
|
| Adolescent | 2 | 2023 | 5363 | 0.180 |
Why?
|
| Prevalence | 1 | 2024 | 1455 | 0.170 |
Why?
|
| Drug Administration Schedule | 1 | 2019 | 143 | 0.160 |
Why?
|
| Emergency Service, Hospital | 1 | 2019 | 208 | 0.150 |
Why?
|
| Internship and Residency | 1 | 2018 | 125 | 0.150 |
Why?
|
| Health Surveys | 1 | 2019 | 373 | 0.150 |
Why?
|
| Depressive Disorder | 1 | 2018 | 174 | 0.140 |
Why?
|
| Hospitalization | 1 | 2019 | 388 | 0.130 |
Why?
|
| Risk-Taking | 1 | 2019 | 451 | 0.130 |
Why?
|
| Sex Factors | 1 | 2018 | 898 | 0.130 |
Why?
|
| Universities | 1 | 2018 | 442 | 0.130 |
Why?
|
| Body Mass Index | 1 | 2019 | 854 | 0.120 |
Why?
|
| Tumor Suppressor Protein p53 | 2 | 2013 | 213 | 0.120 |
Why?
|
| Receptors, Granulocyte Colony-Stimulating Factor | 1 | 2013 | 8 | 0.110 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2013 | 128 | 0.100 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2013 | 172 | 0.100 |
Why?
|
| Male | 2 | 2023 | 20025 | 0.100 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2013 | 222 | 0.100 |
Why?
|
| Child | 1 | 2019 | 3131 | 0.100 |
Why?
|
| Counseling | 1 | 2023 | 116 | 0.050 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 2 | 2013 | 306 | 0.050 |
Why?
|
| Cell Line, Tumor | 2 | 2013 | 2231 | 0.040 |
Why?
|
| HCT116 Cells | 1 | 2013 | 35 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-mdm2 | 1 | 2013 | 40 | 0.030 |
Why?
|
| Mice, Inbred NOD | 1 | 2013 | 45 | 0.030 |
Why?
|
| Neoplasm Transplantation | 1 | 2013 | 122 | 0.030 |
Why?
|
| Granulocyte Colony-Stimulating Factor | 1 | 2013 | 41 | 0.030 |
Why?
|
| Imidazoles | 1 | 2013 | 126 | 0.030 |
Why?
|
| Mice, SCID | 1 | 2013 | 150 | 0.030 |
Why?
|
| Piperazines | 1 | 2013 | 111 | 0.030 |
Why?
|
| Neoplastic Stem Cells | 1 | 2013 | 78 | 0.030 |
Why?
|
| STAT3 Transcription Factor | 1 | 2013 | 90 | 0.030 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2013 | 239 | 0.020 |
Why?
|
| Prognosis | 1 | 2013 | 739 | 0.020 |
Why?
|
| Mice, Transgenic | 1 | 2013 | 617 | 0.020 |
Why?
|
| Phenotype | 1 | 2013 | 689 | 0.020 |
Why?
|
| Cell Differentiation | 1 | 2013 | 587 | 0.020 |
Why?
|
| MicroRNAs | 1 | 2013 | 426 | 0.020 |
Why?
|
| Apoptosis | 1 | 2013 | 1398 | 0.020 |
Why?
|
| Mice | 1 | 2013 | 5913 | 0.010 |
Why?
|
| Animals | 1 | 2013 | 15081 | 0.010 |
Why?
|